ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease

Status: Not yet recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Pilot study of the possible clinical response to anti reflux mucosal ablation in patients with chronic refractory reflux disease

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: No
View:

• typical reflux symptoms more than 2x per week during PPI therapy more than 6 month

• proof of gastro-esophageal reflux in pH metry oder pH/Impedance measurement

Locations
Other Locations
Germany
Klinikum Garmisch-Partenkirchen
Garmisch-partenkirchen
Time Frame
Start Date: July 14, 2022
Estimated Completion Date: May 31, 2023
Participants
Target number of participants: 15
Treatments
Experimental: Mucosa Ablation Arm
Treatment group
Related Therapeutic Areas
Sponsors
Leads: Klinikum Garmisch-Patenkirchen

This content was sourced from clinicaltrials.gov